{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:27:27Z","timestamp":1770071247073,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.amjcard.2004.07.083","type":"journal-article","created":{"date-parts":[[2005,2,9]],"date-time":"2005-02-09T06:47:22Z","timestamp":1107931642000},"page":"1155-1160","source":"Crossref","is-referenced-by-count":41,"title":["Importance of in-hospital initiation of evidence-based medical therapies for heart failure\u2014a review"],"prefix":"10.1016","volume":"94","author":[{"given":"Gregg C.","family":"Fonarow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2004.07.083_bib1","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","article-title":"ACC\/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib2","doi-asserted-by":"crossref","first-page":"1A","DOI":"10.1016\/S0002-9149(99)00358-6","article-title":"Consensus recommendations for the management of chronic heart failure","volume":"83","author":"Packer","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.amjcard.2004.07.083_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.07.083_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.07.083_bib6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure","volume":"316","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.07.083_bib7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2004.07.083_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.07.083_bib9","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2004.07.083_bib10","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.07.083_bib11","first-page":"S49","article-title":"ADHERE (Acute Decompensated Heart Failure National Registry): rationale, design, and subject population (abstr.)","volume":"8","author":"Fonarow","year":"2002","journal-title":"J Card Fail"},{"issue":"suppl IV","key":"10.1016\/j.amjcard.2004.07.083_bib12","first-page":"447","article-title":"Variation in heart failure quality of care indicators among U.S. hospitals: analysis of 230 hospitals in ADHERE","volume":"108","author":"Fonarow","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.07.083_bib13","doi-asserted-by":"crossref","unstructured":"Yancy CW, Chang SF. Clinical characteristics and outcomes in patients admitted with heart failure with preserved systolic function: a report from the ADHERE database (poster 311). Presented at the 77th Annual Meeting of the Heart Failure Society of America; Las Vegas, Nevada; September 22, 2003.","DOI":"10.1016\/S1071-9164(03)00151-9"},{"key":"10.1016\/j.amjcard.2004.07.083_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0735-1097(02)02670-0","article-title":"The underutilization of cardiac medications of proven benefit, 1990 to 2002","volume":"41","author":"Stafford","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/S0140-6736(02)11601-1","article-title":"Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey","volume":"360","author":"Cleland","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2004.07.083_bib16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1592\/phco.19.16.1296.30880","article-title":"Underutilization of ACE inhibitors in heart failure","volume":"19","author":"Luzier","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.amjcard.2004.07.083_bib17","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/01.CIR.0000070952.08969.5B","article-title":"Improving guideline adherence. a randomized trial evaluating strategies to increase B-blocker use in heart failure","volume":"107","author":"Ansari","year":"2003","journal-title":"Circulation"},{"issue":"suppl 3","key":"10.1016\/j.amjcard.2004.07.083_bib18","first-page":"S2","article-title":"The role of in-hospital initiation of cardioprotective therapies to improve treatment rates and clinical outcomes","volume":"3","author":"Fonarow","year":"2002","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2004.07.083_bib19","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/archinte.161.18.2223","article-title":"The benefit of implementing a heart failure disease management program","volume":"161","author":"Whellan","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2004.07.083_bib20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0735-1097(02)02379-3","article-title":"Outpatient adherence to \u03b2-blocker therapy after acute myocardial infarction","volume":"40","author":"Butler","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib21","doi-asserted-by":"crossref","first-page":"10A","DOI":"10.1016\/S0002-9149(99)00933-9","article-title":"Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Program at the University of California Los Angeles","volume":"85","author":"Fonarow","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9149(00)01519-8","article-title":"Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)","volume":"87","author":"Fonarow","year":"2001","journal-title":"Am J Cardiol"},{"issue":"suppl II","key":"10.1016\/j.amjcard.2004.07.083_bib23","first-page":"838","article-title":"An institutional heart failure medication program reduces future cardiovascular readmissions and mortality: an analysis of 19,083 heart failure patients (abstr)","volume":"104","author":"Pearson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.07.083_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0735-1097(97)00208-8","article-title":"Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure","volume":"30","author":"Fonarow","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib25","doi-asserted-by":"crossref","unstructured":"Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M. Pre-discharge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the IMPACT-HF (initiation management predischarge process for assessment of carvedilol therapy in heart failure) trial. J Am Coll Cardiol 2003;43:1534\u20131541.","DOI":"10.1016\/j.jacc.2003.12.040"},{"key":"10.1016\/j.amjcard.2004.07.083_bib26","first-page":"357","article-title":"Heart Failure Society of America (HFSA) practice guidelines","volume":"5","year":"1999","journal-title":"J Card Fail"},{"issue":"suppl","key":"10.1016\/j.amjcard.2004.07.083_bib27","first-page":"308","article-title":"Effects of metoprolol-CR in patients with ischaemic and dilated cardiomyopathy: the RESOLVD pilot study (phase II)","volume":"19","author":"White","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2004.07.083_bib28","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jama.289.6.712","article-title":"Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study","volume":"289","author":"Krum","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2004.07.083_bib29","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.94.11.2793","article-title":"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure","volume":"94","author":"Packer","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.07.083_bib30","doi-asserted-by":"crossref","first-page":"26L","DOI":"10.1016\/S0002-9149(97)00846-1","article-title":"Mechanism of action of beta-blocking agents in heart failure","volume":"80","author":"Bristow","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2004.07.083_bib31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/hc1002.105180","article-title":"Tolerability of beta-blocker initiation and titration in the Metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"105","author":"Gottlieb","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2004.07.083_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ahj.2004.03.004","article-title":"Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design","volume":"148","author":"Fonarow","year":"2004","journal-title":"Am Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291490401166X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291490401166X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T21:30:40Z","timestamp":1548797440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291490401166X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S000291490401166X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2004.07.083","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}